產品名稱：Anti-Integrin-β3/ITG-β3/CD61/FITC,熒光素標記整合素-β3抗體

中文名稱：FITC標記的整合素β3抗體

英文名稱：Anti-Integrin beta 3/CD61/FITC

產品編號：HYK-0342R-FITC

產品別名：Integrin beta chain, β3 precursor; Integrin Beta 3; CD 61; CD61; CD61 antigen; GP3A; GPIIIa; HPA 1; HPA 4; Integrin beta 3 （plaet glycoprotein IIIa antigen CD61）; Integrin beta chain beta 3; ITG B3; ITGB 3; ITGB3; NAIT; Plaet fibrinogen receptor beta subunit; Plaet glycoprotein IIIa; plaet glycoprotein IIIa precursor; Plaet membrane glycoprotein IIIa; PTP; ITB3_HUMAN.

本公司另供應“FITC標記的整合素β3抗體”的其他標記有：Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647 AP APC Biotin Cy3 Cy5 Cy5.5 Cy7 FITC Gold HRP PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 RBITC.

保存條件：Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

Anti-Integrin-β3/ITG-β3/CD61/FITC,熒光素標記整合素-β3抗體 的產品介紹：
The ITGB3 （Integrin beta chain beta 3） protein product is the integrin beta chain beta 3. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in plaets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling.

產品規(guī)格：100ug
產品濃度： 2mg/1ml
亞 型： IgG
純化方法：affinity purified by Protein A
儲 存 液：0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
產品類型：標記一抗
抗體來源：Rabbit
克隆類型：polyclonal 

Anti-Integrin-β3/ITG-β3/CD61/FITC,熒光素標記整合素-β3抗體 相關產品:

脂蛋白磷脂酶A2抗體 Anti-PAFAH/Lp-PLA2
肌動蛋白結合蛋白DOC6抗體 Anti-Advillin/AVIL
乳腺癌易感基因相關蛋白2抗體 Anti-PALB2
原鈣粘附蛋白α5抗體 Anti-PCDHA5
血小板活化因子抗體 Anti-PAF
關節(jié)炎相關基因抗體 Anti-PADI4
骨形態(tài)發(fā)生抑制蛋白SOST抗體 Anti-Sclerostin
腺苷酸環(huán)化酶激活肽-38抗體 Anti-PACAP-38
血影蛋白A鏈紅細胞型抗體 Anti-Spectrin alpha chain, erythrocytic 1
腺苷酸環(huán)化酶激活肽-27/38抗體 Anti-PACAP-27/38